Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: Sub-Q Versus IV Furosemide in Acute Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing subcutaneous versus intravenous furosemide in acute heart failure has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Congestive Heart Failure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-11-17